Report date: 03 Oct 2025
Current price: $187.83 (intraday)
Current P/E (TTM, range from reputable trackers): ~23–33x (methodology differs by source). Benchmarks: 23.9x (Macrotrends), 33.4x (CompaniesMarketCap).
Forward P/E reference: ~13.8x (TradingView). (Macrotrends)
Micron is a cycle-quality name now benefiting from a structure change (HBM). As Buffett/Munger types, we don’t chase optical P/Es at the top of a semi up-leg; we buy great operators at reasonable prices on pullbacks. If you must own the memory leg of AI: size it, demand a margin of safety (my $155–170 band), and let the HBM option ladder be your thesis—not just a chart.
1) Company Overview
| Item | Answer |
|---|---|
| 1.1 What does the company do? | Leading producer of memory & storage (DRAM, NAND, HBM) for data center, PC/mobile, auto/industrial. |
| 1.2 Sector / sub-sector | Technology → Semiconductors → Memory. |
| 1.3 TAM | Management sees mid-teens bit-demand CAGR for both DRAM & NAND over the medium term; data center drove 56% of FY25 revenue, with HBM contributing materially. (Micron Technology) |
| 1.4 Main competitors & share | DRAM: SK hynix, Samsung, Micron. Q2’25 market shares: SK hynix 38.7%, Samsung 32.7%, Micron 22%. (TrendForce) |
| 1.5 Concentration? | No single-customer disclosed >10% in FY25 presentations; end-markets diversified (Cloud/Data Center, Mobile/Client, Auto/Embedded). Business-unit mix in FQ4-25: Cloud 40%, Core Data 14%, Mobile/Client 33%, Auto/Embedded 13%. (Micron Technology) |
My take (score 5/5): Micron is a pure-play memory scale operator with rising HBM mix—exactly where AI capex flows. The business is cyclical, but today’s demand is structurally supported by data-center AI (HBM, DDR5) and growing auto/embedded content. Competitive set is tight; execution and node/packaging cadence matter more than “brand.” As Buffett/Munger types, we don’t love commodity cycles—unless the cost curve and discipline are improving, which they are.
2) Quick Screen
| Check | Data / Comment |
|---|---|
| 2.1 Debt-to-equity | ~0.28x (Aug-25). (YCharts) |
| 2.2 Registered address (HQ) | 8000 S. Federal Way, Boise, Idaho 83716-9632, USA. |
| 2.3 Scandal/Fraud (company) | Historical industry DRAM price-fixing era (2000s). Micron not fined by EU in 2010 decision; a Micron executive pled guilty to obstruction in 2003. Several suits against DRAM makers were later dismissed in U.S. courts. (European Union) |
| 2.4 Scandal/Fraud (promoters) | N/A (widely held U.S. public co.; no “promoters” in Indian sense). |
| 2.5 Debtor days | ~67–72 days on recent prints (varies by calc). (GuruFocus) Good debtor days |
| 2.6 Market cap | ~$210B (Oct 2025). (StockAnalysis) |
| Small/Mid/Large? | Mega-cap U.S. semiconductor. |
| 2.7 Cash & investments | $11.9B cash/marketable investments/restricted cash (FY25 year-end). Liquidity cited as $15.4B incl. facilities. (Micron Technology) |
| 2.8 Free cash flow | FY25 adj. FCF $3.72B; Q4’25 adj. FCF $803M. (Micron Technology) |
| 2.9 FX exposure | Global footprint; China restrictions create geopolitical exposure (e.g., 2023 China ban on key infrastructure). (CSIS) |
My take (score 4/5): Balance sheet leverage is modest; liquidity is ample for heavy capex. Legacy antitrust clouds are historical, but geopolitics (China exposure) is the live risk.
Collection cycle is reasonable for a tier-1 semiconductor supplier. Quick Screen passes comfortably.
3) Shareholder Alignment
| Check | Data / Comment |
|---|---|
| 3.1 Past allegations | See DRAM era notes (historical). (Department of Justice) |
| 3.2 “Promoters” & track record | U.S. governance with CEO Sanjay Mehrotra (ex-SanDisk co-founder), strong memory pedigree. (Wikipedia) |
| 3.3 Promoter ownership | N/A (institutionally held). |
| 3.4 Pledging | Not applicable (no promoter pledges). |
| 3.5 Openness | Rich IR cadence—presentations, press releases, prepared remarks with non-GAAP bridges and guidance. (Micron Technology) |
| 3.6 IPO use of proceeds | Listed since 1984; not relevant. |
| 3.7 Institutions | Institutions own ~80–84%; top holders include Vanguard, BlackRock, Capital World. (Yahoo Finance) |
| 3.8 Insider trading | CFO 10b5-1 plan to sell up to ~$20M through 2026 (first sales since 2022)—routine diversification. (Barron’s) |
| 3.9 Dividend policy | Symbolic dividend (e.g., $0.115/sh in Oct-25); buybacks opportunistic; capex prioritized. (Micron Technology) |
My take (score 4/5): Governance is “big-cap U.S. standard.” Institutional base is sticky; communication is detailed. Insider plan isn’t a red flag. If you want “owner-operator” skin-in-the-game, this isn’t it—but the capital allocation is pragmatic for a capex-heavy cyclical.
4) Performance
| Metric | Latest |
|---|---|
| 4.1 Share price | $187.83 (intraday). |
| 4.2 P/E | See range above; forward P/E ~13.8x. (TradingView) |
| 4.3 Sales trend | FY25 revenue $37.4B (+~49% YoY). (Micron Technology) |
| 4.4 Profit (PAT) | Non-GAAP FQ4-25 net income $3.47B; margins sharply higher YoY. (Micron Technology) |
| 4.5 EPS | Non-GAAP FQ4-25 EPS $3.03; FQ1-26 guide $3.75 ± $0.15. (Micron Technology) |
| 4.6 Margin stability | Gross margin ~46% in FQ4-25; guide ~51.5% for FQ1-26 (mix + HBM). (Micron Technology) |
| 4.7 Segment mix | DRAM 79% / NAND 20% in FQ4-25; data-center 40% of Q revenue. (Micron Technology) |
My take (score 5/5): We’re clearly in an upswing: pricing + mix (HBM/DDR5) + cost downs are flowing through. The step-function jump in margins/EPS and the FQ1 guide show operating leverage typical of this cycle—but remember where we are in the cycle.
5) Efficiency
| Metric | Reading |
|---|---|
| 5.1 OPM | Non-GAAP op margin 35% in Q4-25 (vs 26.8% prior qtr; 22.5% YoY). (Nasdaq) |
| 5.2 ROCE | Expanding sharply with recovery; (proxy via EV/EBIT and margin ramp). |
| 5.3 ROE | Turning up with profitability; still volatile through cycle. |
| 5.4 ROCE vs ROE | ROCE likely > ROE in ramp phase due to delevered balance sheet. |
| 5.5 Debtor days | ~67–72 days recent. (GuruFocus) |
| 5.6 Asset turnover | Improving with utilization; fixed-asset turnover ~2.0 (FY25 snapshot). (MarketBeat) |
| 5.7 Working capital cycle | Shortening vs FY24 as inventories & AR normalize. |
| 5.8 Inventory days | ~124–148 days (varies by source/method), trending down vs FY24. (GuruFocus) |
My take (score 4/5): Operating gearing is excellent on the up-leg. WC metrics are moving the right way. The watch-out: as ASPs cool later in the cycle, these metrics will give back—that’s the memory business.
(As average selling prices (ASPs) for semiconductors fall later in a cycle, it usually indicates market oversupply and declining demand. )
6) Financial Risk
| Check | Status |
|---|---|
| 6.1 Debt | ~$14–16B total; D/E ~0.28x. Manageable given cash and earnings power. (Finance Charts) |
| 6.2 Pre-IPO debt | Not applicable. |
| 6.3 Future debt plan | Capex stepping higher in FY26 (1γ DRAM, HBM capacity); expect higher capex vs FY25. Liquidity supports it. (Micron Technology) Capex stepping higher in FY26 Classic over stretch? |
| 6.4 Credit rating | (External rating not cited in IR; large-cap semi peers are investment grade; treat as investment-grade-like risk.) |
| 6.5 Contingent liabilities | None material disclosed beyond standard semi risks. |
| 6.6 Legal/Regulatory | China limitations remain a live tail risk to shipments and customer quals. (CSIS) |
My take (score 4/5): Balance sheet fine; capex intensity is the real “risk,” but it’s choiceful and supported by free cash flow and the AI/HBM thesis. Macro/trade policy remains the joker.
7) Volume & Liquidity
| Check | Status |
|---|---|
| 7.1 Liquidity | Mega-cap NASDAQ; heavy daily volume. (Yahoo Finance) |
| 7.2 Holder base trend | High institutional ownership (80%+), stable. (Yahoo Finance) |
| 7.3 Promoter pledge | N/A. |
| 7.4 Institutional exit | No broad exit signal; targets have been rising through 2025. (Investopedia) |
| 7.5 Volatility | Elevated vs S&P; normal for semis in upcycle. |
My take (score 5/5): A+ tradability. No liquidity constraints for entries/exits or scaling.
8) Valuations
| Lens | Reading |
|---|---|
| 8.1 P/E (now) | TTM ~23–33x; forward ~13.8x (cycle-peak EPS ramp). (Macrotrends) |
| 8.2 PAT growth vs P/E | Growth currently outpacing multiple expansion—GARP-friendly on forward EPS. Super |
| 8.3 Mcap/Sales | EV/Sales ~5.7x (FY25 context). (StockAnalysis) |
| 8.4 P/B | Book per share (mrq) ~$48.36; P/B ~3.9x at $187.83. (Yahoo Finance) |
| 8.5 Dividend yield | De minimis (capital returns tilted to future buybacks when cycle allows). (Micron Technology) Interesting comment indeed De Minimis… |
| 8.6 Mcap vs fundamentals | Mcap surged with AI/HBM—not cheap on TTM, reasonable on forward. (StockAnalysis) |
| 8.7 PEG | Very favorable on FY26–27 EPS ramps (various trackers show low PEG). (StockAnalysis) |
| 8.8 EV/EBITDA | ~11.8x (FY25 snapshot). (StockAnalysis) |
| 8.9 Vs 5-yr avg | Above mid-cycle averages; justified by HBM optionality. |
My take (score 4/5):
On forward metrics, MU is not expensive for a company stepping into a structurally bigger profit pool (HBM).
On trailing, it looks dear—classic cyclical optical trap.
Use through-cycle yardsticks, not last year’s trough.
“Through-cycle yardsticks” are standards or benchmarks used to evaluate a company’s or asset’s performance over an entire economic cycle, rather than at a single, favorable moment in time.
This approach helps to create a more resilient and realistic assessment by factoring in both periods of economic expansion and contraction.
9) Growth Components
| Driver | Evidence |
|---|---|
| 9.1 Market cap trajectory | Up >100% YoY into mega-cap territory (AI-capex wave). (StockAnalysis) AI-capex wave |
| 9.2 Sales growth | FY25 +~49% to $37.4B. (Micron Technology) |
| 9.3 Profit growth | Q4’25 non-GAAP net income $3.47B, record margins. (Micron Technology) |
| 9.4 OPM growth | Non-GAAP op margin 35% in Q4 vs 22.5% YoY. (Nasdaq) |
| 9.5 Capex | $13.8B FY25; FY26 higher for 1γ DRAM + HBM. (Micron Technology) |
| 9.6 Moats | Cost curve/scale, advanced nodes (1β→1γ), HBM packaging, enterprise quals. |
| 9.7 Customers | Diversified across hyperscalers, OEMs, auto; Cloud 56% FY25 revenue. (Micron Technology) |
| 9.8 Employees | Not provided here; large global base aligned to fab ramps. |
| 9.9 R&D | Embedded in high capex; rapid HBM & node cadence (HBM4 leadership press). (TechRadar) |
| 9.10 Expansion | U.S. fab build-out; ~$200B U.S. investment plan (multi-year). (Reuters) |
| 9.11 ESG/Green | Standard U.S. large-cap disclosures; PFAS/regulatory items noted in 10-K. (Micron Technology) |
| 9.12 Succession | Experienced bench; CEO is sector veteran (since 2017). (Wikipedia) |
My take (score 5/5):
Demand is secular (AI/data center) with cyclical amplitude layered on top.
U.S. on-shoring + incentives deepen the moat.
The HBM “ladder” (HBM3E → HBM4 → HBM4E) can support multi-year pricing power if yields/thermals hold.
The HBM “ladder” refers to the generational roadmap of High Bandwidth Memory, a type of 3D-stacked memory used for AI and high-performance computing. Each successive tier of the ladder—HBM3E, HBM4, and HBM4E—represents a significant improvement in bandwidth, capacity, and power efficiency
Section Scores & Total
(Excluding Company Overview & Quick Screen)
- Shareholder Alignment: 4/5
- Performance: 5/5
- Efficiency: 4/5
- Financial Risk: 4/5
- Volume & Liquidity: 5/5
- Valuations: 4/5
- Growth Components: 5/5
Total: 31 / 35 – 88%
Very High Result
Price & PE Outlook (2-Year Base Case)
Assumptions (explicit):
- FY26–27 DRAM/NAND bit demand mid-teens CAGR; HBM mix rises; gross margin sustains high-40s/low-50s near-term, normalizing later. (Micron Technology)
- Forward P/E re-rates toward 16–18x mid-cycle as EPS normalizes; bull case carries 18–20x on durable HBM leadership; bear case 11–12x if AI digestion hits.
| Scenario (to ~Oct-2027) | EPS est. (TTM) | P/E | Price |
|---|---|---|---|
| Base | $12.5 | 17x | $212 |
| Bull | $14.0 | 19x | $266 |
| Bear | $10.0 | 12x | $120 |
Base-case expected price: ~$212 → +13% vs $187.83; implied base PE ~17x. (Forward math anchored to today’s ~13.8x and management’s stronger near-term margin guide.) (TradingView)
My Recommended Buy Price (discipline for a cyclical)
Buffett/Munger-style guardrails for memory cycles (“Cycle-Safe Buy Box”):
- ≤ 3.0× book (mrq book ≈ $48.36 → ≤ ~$145). (Yahoo Finance)
- Or ≤ 12× forward EPS (your model’s next-12-mo EPS).
- Or EV/EBITDA ≤ 9–10× on your forward bridge. (StockAnalysis)
Actionable band:
- Aggressive buy: $140–155
- Accumulation on weakness: $155–170
- Hold/Add only on dips: $170–190 (today we’re here; buy only if your HBM conviction is high and time horizon is 3–5 years).
“Owner’s Manual” — Three new frameworks to think about MU
- HBM Option Ladder
- Tier 1 (Now): HBM3E volume ramps, ASPs strong → operating leverage.
- Tier 2 (12–24 mo): HBM4 leadership (bandwidth & custom base-die options) sustains premium. (TechRadar)
- Tier 3 (24–48 mo): Packaging/yield mastery → sustained ROCE vs prior cycles.
Use: Size your position based on how many tiers you believe MU can monetize.
- Through-Cycle Book & Cash Test(for commodity-leaning moats)
- Buy below 3× P/B or when OCF/Capex > 1.2× on your next-12-mo model.
- Sell/trim when P/B > 4× and margins >50% for >2 quarters (cycle red-zone).
- Memory Triad(to avoid narrative traps)
- Node cadence (1β→1γ), Package (HBM) yields, Customer quals.
Hit 2/3 = hold/add; all 3 = willing to pay market multiple; <2/3 = wait for price.
- Node cadence (1β→1γ), Package (HBM) yields, Customer quals.
Purchase Price (one-line answer)
Recommended buy price: $155–170 for patient accumulation; $140–155 for aggressive adds (margin-of-safety zone).
Appendix: Key Operating & Market Facts (recent, for your model)
- FY25 revenue: $37.4B; FQ4-25 revenue $11.3B. (Micron Technology)
- FQ1-26 guide: Revenue $12.5B ± $0.3B, GM 51.5% ± 1%, EPS $3.75 ± $0.15 (non-GAAP). (Micron Technology)
- Adj. FCF FY25: $3.72B; cash & investments $11.94B. (Micron Technology)
- Capex: FY25 $13.8B; FY26 higher for 1γ + HBM. (Micron Technology)
- DRAM share (Q2’25): Micron 22%. (TrendForce)
Owners / Leadership Profile — and any unsavory elements
| Topic | Notes |
|---|---|
| CEO | Sanjay Mehrotra (since 2017), co-founded SanDisk; deep memory expertise. (Wikipedia) |
| Top holders | Vanguard, BlackRock, Capital World, State Street, Fidelity—institutional >80%. (Yahoo Finance) |
| Governance | Standard U.S. large-cap board processes, detailed IR. (Micron Technology) |
| Historical “unsavory” | Early-2000s industry price-fixing environment: a Micron executive pled guilty to obstructing a grand-jury investigation (2003); EU’s 2010 cartel fine targeted other DRAM makers; later U.S. class actions (2016–18) were dismissed. Today, key geopolitical risk is China’s partial ban on Micron chips (2023). (Department of Justice) |
My take: Nothing currently suggests management malfeasance; the old DRAM era is a known blemish across the industry, not a current Micron-specific scandal. The more material modern “hair” is China exposure and policy shocks.
Final word (straight talk):
Micron is a cycle-quality name now benefiting from a structure change (HBM). As Buffett/Munger types, we don’t chase optical P/Es at the top of a semi up-leg; we buy great operators at reasonable prices on pullbacks. If you must own the memory leg of AI: size it, demand a margin of safety (my $155–170 band), and let the HBM option ladder be your thesis—not just a chart.
• Downward derating (if receivables + governance cracks): ~20%
Horizons 
Leave a comment